Friday, November 10, 2017 4:50:06 PM
If you take a second look at the numbers Fred gove us, you will notice Accord has biggest sales. Accord was the first to get generic XR approved a year ago, but it was only 400mg tablet. Accord does not yet have 50mg strength at all.
Lupin has second big sales. It got approval together with IPCI, PAR, Pharmadax and Accord for other strengths. This happened may 17 this year as we all know.
AstraZeneca is of course the original manufacturer and it has had XR version since 2007.
So - IPCI/MNK should be quite much at the same level at least with PAR and Pharmadax. Accord entered market second, but it does not have 50mg strength.
Accord sales is more than 150 times bigger than MNK and Lupin sales is more than 50 times bigger. Even thoug they did have approval the very same day as IPCI.
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM